CD200 and narcolepsy: Using mass spectrometric analyses, Luo and co-workers failed to detect OX2-specific cross-reactive autoantibodies in any of the serum specimens of forty post-Pandemrix narcolepsy cases, suggesting that OX2-specific autoantibodies are not a characteristic feature of Pandemrix-associated narcolepsy [29].